Business Context and Reporting Period
This Form 8-K filing by Organogenesis Holdings Inc. is dated January 4, 2019. The report addresses a decision by the Nasdaq Hearings Panel regarding the listing status of the Company's securities following a hearing held on December 13, 2018.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance and listing status rather than financial performance metrics.
Material Changes and Listing Status
- Warrants Delisting: The Company's warrants were ordered to be delisted from The Nasdaq Stock Market due to non-compliance with the minimum 400 round lot holder requirement (Nasdaq Listing Rule 5515(a)(4)).
- Warrant Trading Suspension: Trading in the warrants was halted and converted to a suspension effective at the market open on January 8, 2019. The warrants are expected to trade over-the-counter (OTC) under the symbol "ORGOW."
- Common Stock Continued Listing: The Panel granted the Company's request to continue listing its Class A common stock on The Nasdaq Capital Market, subject to a compliance plan.
- Common Stock Trading Resumption: The trading halt on Class A common stock, initiated on October 30, 2018, was lifted at the market open on January 8, 2019.
Guidance, Outlook, and Risks
Compliance Deadline: The Company must demonstrate to the satisfaction of Nasdaq Staff and the Panel by March 31, 2019, that it has a minimum of 300 round lot common shareholders and meets all other applicable listing requirements.
Risks and Contingencies:
- If the Company fails to meet the 300 round lot shareholder requirement by March 31, 2019, its Class A common stock will be subject to suspension and delisting.
- The decision is subject to a "call for review" by the Nasdaq Listing and Hearing Review Council for 45 calendar days, which could affirm, modify, or reverse the Panel's decision.
- Forward-looking statements regarding compliance are subject to risks including the ability to implement the compliance plan, competition, and the successful integration of a recent business combination.
Investor Verification Checklist
- Verify the resumption of Class A common stock trading on Nasdaq under the existing symbol on January 8, 2019.
- Confirm the transition of warrant trading to the OTC market under the symbol "ORGOW."
- Monitor the Company's progress toward achieving 300 round lot common shareholders by the March 31, 2019 deadline.
- Check for any "call for review" by the Nasdaq Listing Council within 45 days of the January 4, 2019 decision.